LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

Home・Aktien・Vivani Medical

Vivani Medical

Open

1.37 6.2

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.31

Max

1.38

Schlüsselkennzahlen
By Trading Economics
Angestellte	37

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+203.03% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-15M 89M
Vorheriger Eröffnungskurs	-4.83
Vorheriger Schlusskurs	1.37

Vivani Medical Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

26. Nov. 2025, 17:44 UTC

Ergebnisse

Wichtige Markttreiber

Deere Warns of Tough Year Ahead as Earnings, Sales Fall -- Update

27. Nov. 2025, 00:00 UTC

Market Talk

Rio Tinto's Coming Investor Briefing Seen Focused on Costs, Lithium, Asset Sales -- Market Talk

26. Nov. 2025, 23:47 UTC

Market Talk

Nikkei May Rise as Fears About Potential AI Bubble Ease -- Market Talk

26. Nov. 2025, 23:28 UTC

Market Talk

Mortgage Refinancing in New Zealand Will Spur Recovery -- Market Talk

26. Nov. 2025, 23:21 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

26. Nov. 2025, 23:21 UTC

Market Talk

RBNZ Rate Cuts Finally Getting Traction With Consumers -- Market Talk

26. Nov. 2025, 23:02 UTC

Market Talk

Steelmaking Coal Price Signal Knocked by China Import Shift -- Market Talk

26. Nov. 2025, 21:38 UTC

Ergebnisse

These Stocks Moved the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. Nov. 2025, 21:25 UTC

Ergebnisse

Li Auto Posts Surprise Loss, Stock Rises. What's Next for Its Diving EV Sales. -- Barrons.com

26. Nov. 2025, 21:17 UTC

Akquisitionen, Fusionen, Übernahmen

Commercial Metals Co Announces Closing of $2B Senior Notes Offering

26. Nov. 2025, 21:16 UTC

Ergebnisse

Deere Beat Earnings Estimates. Why the Stock Is Falling. -- Barrons.com

26. Nov. 2025, 21:09 UTC

Ergebnisse

Roblox Isn't Playing Games. Why the Stock Could -2-

26. Nov. 2025, 21:09 UTC

Ergebnisse

Roblox Isn't Playing Games. Why the Stock Could Jump 50%. -- Barrons.com

26. Nov. 2025, 20:27 UTC

Akquisitionen, Fusionen, Übernahmen

Charter Communications Stock Is a Disaster. The Answer Could Be a 10% Dividend. -- Barrons.com

26. Nov. 2025, 20:25 UTC

Akquisitionen, Fusionen, Übernahmen

Charter Communications Stock Is a Disaster. The Answer Could Be a 10% Dividend. -- Barrons.com

26. Nov. 2025, 20:15 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. Nov. 2025, 20:08 UTC

Market Talk

Oil Futures Settle Higher in Choppy Trade -- Market Talk

26. Nov. 2025, 20:06 UTC

Market Talk

U.S. Natural Gas Settles Higher Ahead of Holiday -- Market Talk

26. Nov. 2025, 19:30 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. Nov. 2025, 19:21 UTC

Akquisitionen, Fusionen, Übernahmen

Teck Resources: ISS and Glass Lewis Recommend Teck Hldrs Vote for Anglo American Deal

26. Nov. 2025, 18:43 UTC

Market Talk

U.S. Natural Gas Storage Down for Second Straight Week -- Market Talk

26. Nov. 2025, 18:41 UTC

Market Talk

U.S. Oil Rig Count Falls By 12 to 407 -- Market Talk

26. Nov. 2025, 18:19 UTC

Ergebnisse

Workday Beat Earnings Estimates. The Stock Is Down 10% Anyway. -- Barrons.com

26. Nov. 2025, 17:51 UTC

Ergebnisse

Deere Forecasts Higher Tariff Costs, Less Profit in 2026 -- WSJ

26. Nov. 2025, 17:50 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Alphabet, Nvidia, AMD, Apple, Dell, Robinhood, Deere, HP Inc., Urban Outfitters, and More -- Barrons.com

26. Nov. 2025, 17:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Energy & Utilities Roundup: Market Talk

26. Nov. 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

26. Nov. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

26. Nov. 2025, 17:16 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Blue Owl Is Having a Rough Year. Its Co-CEO Says -2-

26. Nov. 2025, 17:16 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Blue Owl Is Having a Rough Year. Its Co-CEO Says Investors' Fears Are 'Ungrounded.' -- Barrons.com

Peer-Vergleich

Kursveränderung

Vivani Medical Prognose

Kursziel

By TipRanks

203.03% Vorteil

12-Monats-Prognose

Durchschnitt 4 USD 203.03%

Hoch 4 USD

Tief 4 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vivani Medical – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vivani Medical – Dist abgegeben haben.

Finanzen

Über Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.